avectas | Avectas - Cell Engineering Technology

Keyword	CPC	PCC	Volume	Score	Length of keyword
avectas	1.03	0.7	8570	30	7

Keyword	CPC	PCC	Volume	Score
avectas	0.76	0.4	1514	7
avectas ireland	1.34	0.3	9656	69
avectas technology	0.86	0.6	6968	64
avectas technology news	0.43	0.4	566	79
avectas technology stock	1.04	0.7	6983	99
avectas technology patent	1.8	0.4	3357	73
avectas technology review	0.21	0.1	5845	63
avectas technology address	0.09	0.8	8037	47
avectas technology careers	1.01	0.4	7014	2
avectas technology company	0.23	0.7	6203	26
avectas technology contact	1.04	0.4	6164	41
avectas technology limited	1.28	0.2	7471	68
avectas technology platform	1.15	0.9	471	60
avectas technology ireland	0.93	0.5	1419	9

Search Results related to avectas on Search Engine

Avectas - Cell Engineering Technology
avectas.com:443

https://avectas.com:443/

WEBAvectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized.

DA: 82 PA: 4 MOZ Rank: 54

About Us - Avectas
avectas.com:443

https://avectas.com:443/about-us/

WEBFeb 1, 2023 · Avectas is accelerating the future of cell therapy through an easy-to-integrate and flexible delivery platform that manufactures healthier and more functional cells for patients.

DA: 69 PA: 29 MOZ Rank: 73

Technology - Avectas
avectas.com:443

https://avectas.com:443/technology/

WEBTechnology - Avectas. Our technology. Solupore®. Current gene delivery technologies for cell therapy applications rely on harsh mechanisms which negatively impact cell quality. This impact to cell health results in reduced proliferative capacity and cell function following the delivery of cargo.

DA: 65 PA: 80 MOZ Rank: 61

Team - Avectas
avectas.com:443

https://avectas.com:443/team/

WEBGet in Touch. Meet the people behind Avectas and the Solupore platform that offers a cell engineering solution for next generation cell and gene therapies.

DA: 80 PA: 29 MOZ Rank: 44

Avectas Launches the Solupore® Platform for the Clinical …
avectas.com:443

https://avectas.com:443/avectas-launches-the-solupore-platform/

WEBJan 16, 2023 · DUBLIN, Ireland and CAMBRIDGE, MA – 16 January 2023: Avectas, a cell engineering technology leader, announces the launch of the Solupore® platform at the Advanced Therapies Week, Miami Beach Convention Centre, January 17th – …

DA: 55 PA: 38 MOZ Rank: 18

News & Articles - Avectas
avectas.com:443

https://avectas.com:443/news-articles/

WEBFeb 1, 2023 · Killer cells: delivering a knockout blow to cancers. Find all the latest news and articles at Avectas. Keep up to date on the Solupore non-viral delivery system that enables the next generation of cell therapies through unparalleled cell …

DA: 80 PA: 48 MOZ Rank: 93

Partners - Avectas
avectas.com:443

https://avectas.com:443/partners/

WEBUC Davis. Avectas has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterisation of cells engineered with Avectas’ proprietary, non-viral SOLUPORE® cell engineering platform.

DA: 70 PA: 22 MOZ Rank: 39

AVECTAS leading the way in non-viral cell engineering technology
avectas.com:443

https://avectas.com:443/avectas-leading-the-way-in-non-viral-cell-engineering-technology/

WEBDec 29, 2022 · The project will take AVECTAS further towards commercialising an advanced, large-scale, digitalised cell engineering platform optimised to manufacture ‘off-the-shelf’ cell-based therapies for cancer treatment.

DA: 9 PA: 11 MOZ Rank: 71

Avectas | LinkedIn
linkedin.com:443

https://www.linkedin.com:443/company/avectas

WEBAvectas | 4,212 followers on LinkedIn. Excelling beyond | Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and...

DA: 23 PA: 7 MOZ Rank: 34

Avectas: engineering the future of cell therapy
nature.com:443

https://www.nature.com:443/articles/d43747-020-00834-6

WEBAvectas, a small biotech company based in Dublin, Ireland, specializes in the ex vivo delivery of advanced molecules such as mRNA, proteins and gene-editing payloads like CRISPR–Cas9 for...

DA: 48 PA: 5 MOZ Rank: 92